GOSS
Gossamer Bio, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +20.0% ·
flujo de acciones +16.8% ·
nuevas posiciones netas +16.7%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 60 | -10 | 149.84M | $24.67M | +3 | −14 |
| Q1 2026 | 73 | -3 | 96.26M | $32.15M | +6 | −9 |
| Q4 2025 | 76 | -1 | 88.23M | $273.50M | — | −1 |
| Q3 2025 | 18 | +3 | 53.94M | $141.87M | +3 | — |
| Q2 2025 | 12 | 0 | 44.92M | $55.25M | +1 | −1 |
| Q1 2025 | 9 | +1 | 11.42M | $12.56M | +1 | — |
| Q4 2024 | 8 | 0 | 11.95M | $10.80M | — | — |
| Q3 2024 | 7 | 0 | 18.68M | $18.44M | — | — |
| Q2 2024 | 7 | — | 23.16M | $20.86M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 13.85M | +14.0% | $36.42M | 0.0% | ▲ Add | 2 | SEC ↗ ×7 |
| 2 | The Vanguard Group ✦ (pasivo) | 12.01M | +5.2% | $31.59M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 3 | Geode Capital Management ✦ (pasivo) | 4.69M | +3.0% | $12.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | Fidelity (FMR) ✦ | 4.09M | -44.1% | $10.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (pasivo) | 3.88M | +56.5% | $10.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Millennium Management ✦ | 3.62M | +629.3% | $9.52M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 2.98M | +9.1% | $7.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 2.29M | +31.1% | $6.02M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 2.28M | +197.6% | $6.01M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Adage Capital Partners ✦ | 726.80K | Nuevo | $1.91M | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 646.62K | Nuevo | $1.70M | 0.0% | New | 1 | SEC ↗ ×5 |
| 12 | Wellington Management ✦ | 641.72K | Nuevo | $1.69M | 0.0% | New | 1 | SEC ↗ ×3 |
| 13 | Arrowstreet Capital ✦ | 635.40K | -43.2% | $1.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 566.42K | — | $1.49M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 15 | JPMorgan Chase ✦ | 388.74K | — | $1.02M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 16 | Goldman Sachs Group ✦ | 299.58K | — | $787,900 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | D. E. Shaw & Co. ✦ | 248.82K | +338.0% | $654,391 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 18 | T. Rowe Price ✦ | 100.66K | +5.6% | $265,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Adage Capital Partners | $1.91M | 0.0% |
| AQR Capital Management | $1.70M | 0.0% |
| Wellington Management | $1.69M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 2.17M acciones, $845,282 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.